Microbiological Characteristics of Unresolved Acute Uncomplicated Cystitis

Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
Hee Youn KimHyun-Sop Choe

Abstract

This study sought to compare the antimicrobial susceptibility rates between acute uncomplicated cystitis patients with failed initial antimicrobial treatment, who were considered unresolved cases, and newly presenting acute uncomplicated cystitis patients without recent antimicrobial use within 3 months and to determine whether different treatment strategies should be applied according to recent antimicrobial exposure (RAE). Female acute uncomplicated cystitis patients with Escherichia coli growth, who visited our hospital's urology department from 2010 to 2014, were divided according to RAE. The antimicrobial susceptibility of E. coli was compared between the group with RAE and the group with no antimicrobial exposure (NAE) within 3 months. The total number of acute uncomplicated cystitis patients with E. coli growth was 259: 40 patients comprised the RAE group and 219 patients formed the NAE group. The mean age was significantly older and previous recurrent cystitis history was higher in the RAE group (p < 0.05). Furthermore, the antimicrobial susceptibility of E. coli to amoxicillin-clavulanic acid, cefotaxime, cefoxitin, ciprofloxacin, and trimethoprim-sulfamethoxazole was significantly lower in the RAE group, with suscepti...Continue Reading

References

Sep 9, 2000·Archives of Internal Medicine·E Lifshitz, L Kramer
Jul 13, 2002·The American Journal of Medicine·Betsy Foxman
Oct 5, 2002·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Joong-Sik EomHee-Jin Cheong
May 6, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David L Paterson
Aug 11, 2004·Mayo Clinic Proceedings·Loren G Miller, Angela W Tang
Jun 1, 1994·International Journal of Antimicrobial Agents·G K Harding, A R Ronald
Sep 24, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David A TalanUNKNOWN EMERGEncy ID NET Study Group
Oct 1, 2008·The American Journal of Medicine·Luke JohnsonConnie Savor Price
Sep 16, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P CassierP Chavanet
Dec 9, 2010·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Seung-Ju LeeYong-Hyun Cho
Feb 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kalpana GuptaUNKNOWN European Society for Microbiology and Infectious Diseases
Jan 13, 2012·The Journal of Urology·Alan J Wein
Aug 21, 2013·Antimicrobial Agents and Chemotherapy·Dong Sup LeeSeung-Ju Lee

❮ Previous
Next ❯

Citations

Aug 18, 2018·Therapeutic Advances in Urology·Ekaterina Kulchavenya
Jun 21, 2019·Current Pharmaceutical Design·Lernik Issakhanian, Payam Behzadi
Oct 26, 2018·BioMed Research International·Dong Sup LeeHyun-Sop Choe
Jun 16, 2021·Annals of Rehabilitation Medicine·EunYoung KimBum-Suk Lee

❮ Previous
Next ❯

Methods Mentioned

BETA
urine sediment

Software Mentioned

PASW ( Predictive Analytics Software ) Statistics

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.